Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy

Abstract Background Calls for the coronavirus to be treated as an endemic illness, such as the flu, are increasing. After achieving high coverage of COVID-19 vaccination, therapeutic drugs have become important for future SARS-CoV-2 variant outbreaks. Although many monoclonal antibodies have been ap...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Journal of Biomedical Science
المؤلفون الرئيسيون: Chen-Yi Chiang, Mei-Yu Chen, Chia-Wei Hsu, Chia-Yeh Liu, Yu-Wen Tsai, Hung-Chun Liao, Jia-Ying Yan, Zih-Shiuan Chuang, Hsin-I. Wang, Chien-Hsiung Pan, Chia-Yi Yu, Guann-Yi Yu, Ching-Len Liao, Shih-Jen Liu, Hsin-Wei Chen
التنسيق: مقال
اللغة:الإنجليزية
منشور في: BMC 2022-06-01
الموضوعات:
COVID-19
Monoclonal antibody
Neutralization
SARS-CoV-2
Variant
الوصول للمادة أونلاين:https://doi.org/10.1186/s12929-022-00823-0

الانترنت

https://doi.org/10.1186/s12929-022-00823-0

مواد مشابهة